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Donata Kurpas5,6, Frans Rutten1, Henner Hanssen7,
Maria Antonopoulou8, Paul Dendale9,10 and Diederick
E Grobbee1; on behalf of all PCRFM nucleus members
In recent decades, cardiovascular mortality has reduced
significantly. Among others, improved treatment
options for cardiovascular disease (CVD) and a reduc-
tion of smoking since the 1960s have contributed to this
decline.1 In many countries, smoking in public areas is
prohibited. However, western dietary habits, including
foods high in sugar, salt and fat, and lack of exercise
are still persistent, leading to obesity, diabetes and
hypertension. Yet, despite numerous guidelines on pre-
vention and treatment of CVD with medication and
lifestyle management, the incidence of CVD is still
increasing in many countries, fuelled by rising obesity
levels, sedentary lifestyles and increased longevity.2 In
particular in the southern hemisphere CVD is on the
increase, with high rates of obesity, diabetes and hyper-
tension.3 Demographics are changing in low and
middle income countries, fuelling the rise of chronic
diseases and a persistent burden of infectious diseases
overwhelming the limited health care resources.4 In
western countries survival after CVD events has suc-
cessfully improved; however, at the price of more
patients living with chronic CVDs.5 These develop-
ments will lead to an increased demand on healthcare
services now and in the years ahead for both the pre-
vention and the management of CVD. The organisa-
tion and continuity of care through the various layers
of the different national healthcare systems is challen-
ging and calls for close collaboration between hospital
specialists, general practitioners (GPs) and other pri-
mary care workers in the battle against CVD. GPs
are key in identifying patients at risk of CVD and pro-
viding individualised, risk stratified preventive care.
GPs, primary care nurses and other members of the
primary care team have longstanding relationships with
patients from cradle to grave and have frequent con-
tacts with those enlisted. In adults, CVD or risk factors
are in the top 10 of reasons to consult the general prac-
tice.6 Thus, primary care professionals are in general
the first to identify changes in patients’ CVD risk fac-
tors. The 2016 European Guidelines on cardiovascular
disease prevention in clinical practice recommend the
prevention of CVD to be delivered in all healthcare
settings, including primary care.7 It further recom-
mends that GPs, nurses and allied health professionals
such as physiotherapists, dieticians and psychologists
should work together as a team to provide the most
effective multidisciplinary care. General practice can
offer comprehensive management for patients with
CVD, including those with multiple comorbid condi-
tions. Nevertheless, more implementation of individua-
lised risk-based prevention that focuses on all aspects of
lifestyle and risk factor management is needed.
Important in this perspective of multi-morbidity is the
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risk of overtreatment and conflicting recommendations
from different guidelines.
There is a large variation in the organisation of pri-
mary care within Europe and even more so globally.8
Consequently, the organisation of integrated cardiovas-
cular risk management (CVRM) will show large
variations, depending on factors such as reimburse-
ment, organisation of national healthcare systems, for
example, GP as gate keeper to hospital specialists,
availability of international guidelines translated into
the native language and adapted to the regional
situation.
In some EU countries with a strong primary care
system and reimbursement for cardiovascular risk man-
agement care, integrated cardiovascular risk pro-
grammes for high CVD risk patients have already
been implemented, starting with the point that patients
receive the ‘right care at the right place, in secondary
care if necessary and primary care in collaboration with
specialists if possible’.9 For this purpose, detailed regio-
nal agreements are applied between hospital specialists
and general practices, focused on substitution of care
from hospital to near home setting. The effectiveness of
such care is still under investigation.
The EUROASPIRE studies consistently show that
the proportion of high CVD risk patients actually
reaching treatment goals is modestly improving over
years, but it is still disappointingly low.10 A large
majority of patients are not reaching the recommended
lifestyle and therapeutic goals for blood pressure, lipids
and glucose and furthermore only a minority of
patients are being advised to participate in CVD pre-
vention programmes. Guidelines on management of
CVD and risk factors are very clear on these goals,
but implementation in practice is difficult. More
detailed knowledge is needed to identify barriers for
implementation and possible solutions to provide
better patient centred CVD preventive care.
To address above mentioned challenges, the
European Association of Preventive Cardiology
(EAPC) has launched a new nucleus ‘Primary Care
and Risk Factor Management’ (PCRFM). The aims
are: (i) investigating daily practice, (ii) defining standards
and (iii) promoting CVD prevention in primary care,
including risk-stratified management for those at risk
and with already established cardiovascular disease.’’
The full nucleus was established in February 2019
and members come from different disciplines across pri-
mary and secondary care, all with strong links to pri-
mary care; for example, GPs, cardiologists, vascular
internists, occupational health specialists, nurses,
physiotherapists, psychologists, dieticians and exercise
physiologists.
The PCRFM has committed itself to reaching the
following goals in the coming years:
. Establishing itself as an entity within and outside of
the European Association of Preventive Cardiology,
reaching out to and seeking collaboration with all
relevant stakeholders in specialist and primary care
groups involved in CVD prevention;
. Building a strong network for all disciplines working
in primary care, taking joint action to act as advo-
cates to improve the standards of CVD prevention in
primary care across Europe;
. To help build stronger primary care systems in coun-
tries where this is a prerequisite for adequate preven-
tion and treatment of CVD;
. Contributing to scientific sessions and tracks in
European Society of Cardiology (ESC) conferences
related to multidisciplinary primary CVRM care and
the role of general practice in general CVD prevention;
. Providing position papers that synthesise evidence
relating to risk factor management and delivery of
prevention in primary care and other settings,
including the community and workplace;
. Commenting on ESC guidelines with regard to impli-
cations for primary care, ‘How to’ and contributing
to the development of ESC practice guidelines;
. Developing educational activities in cooperation
with relevant partners for the wide scope of profes-
sionals working in primary care and the community;
. Initiating and contributing to scientific research pro-
jects related to the defined goals.
The PCRFM has a unique position to act as liaison
between various disciplines from primary care and the
different bodies within the ESC and specialist care. The
PCRFM can add value with regard to important
themes for primary care such as, for example, how to
reach the high-risk population, how to deal with multi-
morbidity and how to reach out to the lower income
populations. The launch of the PCRFM section within
the EAPC is a consequence of the growing needs for a
multidisciplinary, patient-centred, individualised
approach for CVD in primary care settings to meet
the growing socio-economic healthcare challenges of
modern society. The section will promote primary
care and risk factor management in Europe and
beyond, facilitating an international network of pri-
mary care professionals with a focus on education,
research and clinical guideline implementation.
https://www.escardio.org/Sub-specialty-communities/
European-Association-of-Preventive-Cardiology-
(EAPC)/About/primary-care-and-risk-factor-manage-
ment-section
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